The search for an effective prophylactic against Chemotherapy-Induced Peripheral Neuropathy (CIPN) has been one of the most frustrating chapters in…
Read More
Marine Compounds From Sea Squirts Show Promise in Reversing Cognitive Decline and Physical Signs of Aging
The inevitability of aging has long been characterized by a predictable decline in biological function, ranging from the graying of…
Read More
Shigellosis Vaccine Shows Promise in Combating Antibiotic-Resistant Bacteria
Scientists have taken a significant step toward developing an effective vaccine against shigellosis, the infection caused by Shigella bacteria. In…
Read More
Revolutionary Plant Wearables from Tufts University Promise a New Era of Precision Agriculture
In a significant leap forward for agricultural technology, researchers at Tufts University in Massachusetts have unveiled a groundbreaking system of…
Read More
Experimental Drug Shows Promise in Clearing Tau Tangles, Offering New Hope for Alzheimer’s Patients
LONDON – An experimental drug has demonstrated the ability to clear toxic tau tangles from the brain, a significant step…
Read More
Rubedo Life Sciences’ RLS-1496 Shows Promise in Treating Precancerous Skin Lesions with Minimal Irritation
For millions worldwide grappling with actinic keratoses (AK), the rough, scaly patches of sun-damaged skin that are precursors to squamous…
Read More
Gene Therapy Shows Significant Promise in Reversing Fragile X Syndrome Deficits in Mice, Offering Hope for Human Treatment
A groundbreaking study led by the University of California, Riverside (CA, USA) has demonstrated that a novel gene therapy successfully…
Read More
Cysteine, a Naturally Occurring Amino Acid, Shows Promise in Enhancing Intestinal Repair and Regeneration
A groundbreaking study by researchers at the Massachusetts Institute of Technology (MIT) has unveiled a significant discovery regarding the regenerative…
Read More
Exercise and Low-Dose Ibuprofen Show Promise in Mitigating Chemotherapy-Induced Cognitive Impairment
For decades, cancer survivors have reported a cloud of mental fog following treatment, a phenomenon colloquially termed "chemo brain." This…
Read More
Lilly’s $7bn Acquisition of Kelonia Bears Fruit as In Vivo Cell Therapies Show Significant Promise at ASCO 2026
The American Society for Clinical Oncology (ASCO) meeting in 2026, a cornerstone event for oncological advancements, has concluded, leaving behind…
Read More
